Clinical trial
COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial).
NCT01552187 is registered in ClinicalTrials.gov with Maria Vittoria Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 Trial).
- Lead sponsor
- Maria Vittoria Hospital
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2012
- Completion date
- July 31, 2014
- Enrollment
- 360 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation, cardiac surgery, pericardial effusion, pleural effusion, post-pericardiotomy syndrome